Latest news
MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law - Business WireBusiness Wire · Sat, 08 Aug 2026 18:57:00 GMTIs Opus Genetics Inc (IRD) Significantly Overvalued After Q2 Ear - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:48:49 GMTMyriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 23:44:17 GMTFulgent Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 23:13:22 GMTPrice to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingViewTradingView · Fri, 07 Aug 2026 20:11:49 GMTMYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 18:54:29 GMTState Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics - Stock TitanStock Titan · Fri, 07 Aug 2026 14:10:28 GMTOpus Genetics, Inc. 2Q 2026: Revenue $0.8M, EPS $(0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMT